After amassing 10 million sign-ups for its AI presentation tool in just nine months, Tome is releasing new features aimed at getting those users to stick around. Tome can turn text prompts into ...

Methods of editing the genome are powering the development of new cell and gene therapies for diseases that have been challenging to treat. Companies like Tome Biosciences are part of a wave of ...

Since its March beta launch, Tome has prided itself on letting users quickly build presentations and tell online stories with just a few clicks or taps. As of today, the app will make it even easier ...

Now valued at $300 million while still pre-revenue, per a source, Tome says it’s the fastest productivity software maker to ever reach 1 million users since its September release. IN a chat box below ...

This is an excerpt of an article from STAT, the health and medicine news site that’s a partner to the Globe. For a full version of this story and related coverage, visit STAT. High-profile gene ...